Christopher Borsa

Revenue and growth executive (CRO, VP of Sales, Area VP) with 20+ years scaling digital health, RPM/CCM SaaS, medical device, and surgical biotech companies, leading national direct and independent sales forces of 300+ representatives. Built or rebuilt six national commercial organizations, including three turnarounds, producing $600M+ in cumulative revenue: Medtronic $0 to $45M, Pacira <$1M to $50M, Aulisa $0 to $12.5M in two years, Vitasora $1.1M to $2.5M+ MRR in the first year.

Vice President of Sales and Marketing at Vitasora Health (2025-08 – Present)

Recruited to lead commercial and business operations with CRO-scope P&L ownership for a high-growth RPM/CCM digital health company serving FQHCs, hospital networks, ACOs, and primary care groups: sales, marketing, account management, RevOps, billing and revenue cycle, and clinical enrollment operations.

• Grew MRR from $1.1M to $2.5M+ (~$30M ARR run rate) in the first year, scaling patient enrollment 233% (4,500 to 15,000) through new logo sales, land-and-expand, provider partnerships, and payor expansion.
• Stood up the national sales, account management, and RevOps organization from zero: hiring, onboarding, territory design, compensation plans, KPI dashboards, and standardized enrollment-to-billing workflows.
• Partnered with engineering to design and launch the company's clinical care-management platform; AI-driven Medicare pre-qualification lifted patient qualification rates 47% and automated eligibility verification, consent, and CPT time-tracking.
• Deployed AI agents across RPM alert triage, prior authorization, and CRM lead scoring and churn-risk flagging, holding commercial headcount flat while enrollment tripled.
• Implemented MEDDICC qualification and Salesforce forecasting discipline, lifting forecast accuracy from 72% to 95%+; established the first national account management function and operating cadence (QBRs, SLA tracking).
• Presented quarterly to the Board and investors; built the revenue model and reporting package supporting fundraising and diligence.

Chief Revenue Officer, North America at Aulisa Medical (2023-06 – 2025-08)

Promoted to Chief Revenue Officer role leading full US commercial operations.

• Grew Hospital RPM revenue from $0 (2022) to $6M (2023) to $12.5M (2024), leading 6 Area VPs and 50 direct representatives plus a national distributor channel while running billing, implementation, and customer support operations.
• Secured net-new IDN contracts with four major national health systems through a GPO/IDN initiative built from scratch.
• Launched the Hospital-at-Home segment (Dec 2024) to $400K MRR and expanded RPM into oral surgery, ASC, ketamine clinic, and ED verticals ($250K+ new revenue).
• Directed the company's AI assistant program from strategy through enterprise implementation: predictive deterioration alerts, ambient documentation, automated prior authorization, and next-best-action sales guidance.
• Upgraded and managed the AI-driven Revenue Cycle Management (RCM) program with account-level tracking of monthly billing and reimbursement performance, strengthening collections visibility and payor accountability.

VP of Sales at Aulisa Medical (2022-11 – 2023-06)

Recruited by the CEO to lead a hospital and commercial SaaS turnaround.

• Built the B2C and B2B business models from scratch, growing B2C revenue from $0 to $250K per month in 4 months; designed the RPM and CCM program models end-to-end: billing operations, reimbursement workflows, sales training, and product roadmap.
• Owned the build of Aulisa's CRM platform, creating the pipeline, lead routing, forecasting, and account management infrastructure that ran the national sales operation.

Chief Revenue Officer at OrthoCor Medical (2020-03 – 2022-11)

• Grew the Workers' Compensation and DoD/VA vertical from $6M to $27M per year (2019 to 2022) and developed the MedLegal (personal injury) vertical, generating $30M+ in billings in 2021 to 2022.
• Built the national sales force and an independent channel of 75+ medical device distributors; created and launched the company's RPM program as CRO, adding $100K per month in recurring revenue.

VP of Global Sales at OrthoCor Medical (2019-01 – 2020-03)

Area Vice President of Sales, Central US at Pacira Biosciences (2014-01 – 2019-01)

• Grew surgical biotech revenue from under $1M to $50M+ in 5 years, directing 30+ OR specialty reps and 4 field directors in the national launch of Exparel for post-operative pain and opioid reduction.
• Ranked #1 or #2 nationally four consecutive years (2014 to 2017); led the nation in revenue in 2015 and 2016; Circle of Excellence winner; led J&J distributor alignment generating $25M+ in annual revenue.

Area Vice President of Sales, Central US at ATEC Spine (2008-03 – 2013-12)

• Turned around the struggling Central Area, growing revenue from $150K to $3.5M per month ($125M+ over the final four years), building an independent distribution network of 250+ representatives.
• Closed the largest surgical systems purchase in company history ($10M+, 2012); #1 nationally in PureGen biologics 2010 to 2011; President's Club 2010 to 2012.

Area Sales Director, Central US at Medtronic (formerly Kyphon, acquired 2007) (2003-07 – 2008-03)

• Grew the Central Area from $0 to a $45M annual run rate and $200M+ cumulative revenue, leading 40 spine consultants and 15 spine education specialists.
• Twenty-eight consecutive quarters of quota achievement; President's Club 2002 to 2008; Sales Director of the Year 2004; developed 30 President's Club winners.
• Opened interventional radiology and interventional pain management as new growth verticals for Balloon Kyphoplasty, generating $15M in first-year IR sales and $40M+ combined in 2007.

Area Sales Manager at Medtronic (formerly Kyphon, acquired 2007) (2001-02 – 2003-07)

Launched Kyphoplasty in the Midwest, building the team from scratch to a $1M per month run rate in 8 months.

B.S. in Business & Industrial Psychology – University of Wisconsin–Madison

Executive Business Program – Washington University in St. Louis